Filter by keywords:



Filtering documents. Please wait...

1/2. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.

    A 67-year-old woman with diabetes mellitus, chronic renal insufficiency, and recurrent urinary tract infections experienced encephalopathy and myoclonus while receiving cefepime. The adverse drug event was accompanied by elevated cefepime levels and abnormal electroencephalograms. This syndrome resolved after discontinuation of cefepime. Neurotoxicity is a known but possibly underreported adverse event associated with cefepime in patients with renal impairment who receive relatively excessive doses. Most cases reverse on drug cessation. In patients with renal disease, the maintenance dosage should be reduced and the patient monitored for neurotoxicity. Cefepime toxicity should be suspected whenever a patient receiving the drug experiences a change in mental status or myoclonus.
- - - - - - - - - -
ranking = 1
keywords = diabetes mellitus, diabetes, mellitus
(Clic here for more details about this article)

2/2. Non-ketotic hyperglycaemia-related paroxysmal bilateral hand paraesthesia misdiagnosed as diabetic neuropathy.

    Non-ketotic hyperglycaemia (NKH)-related partial seizure disorders are not uncommon in clinical practice but still deserve attention as they significantly affect neurologic outcome if unnoticed. The atypical presentation of sensorimotor symptoms can be seen in this setting, with paroxysmal character as the rule. Atypical manifestations could cause confusion and might lead to improper diagnosis and treatment. We report a case of inadequately controlled diabetes mellitus and NKH presenting as paroxysmal paraesthesia of both hands, which was misdiagnosed as diabetic neuropathy.
- - - - - - - - - -
ranking = 1
keywords = diabetes mellitus, diabetes, mellitus
(Clic here for more details about this article)


Leave a message about 'Renal Insufficiency, Chronic'


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.